Rigosertib as a selective anti-tumor agent can ameliorate multiple dysregulated signaling transduction pathways in high-grade myelodysplastic syndrome
Cited by 49
Related Papers
Resveratrol ameliorates atherosclerosis induced by high-fat diet and LPS in ApoE−/− mice and inhibits the activation of CD4+ T cells
|Nutrition & Metabolism|2020|45
Genomic loss of EZH2 leads to epigenetic modifications and overexpression of the HOX gene clusters in myelodysplastic syndrome
|Oncotarget|2016|34
DHX9-mediated pathway contributes to the malignant phenotype of myelodysplastic syndromes
|iScience|2023|9